Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

Cited by (646)

Items 301–400 of 646

1. Monoclonal Gammopathies
   Angela A. Dispenzieri · 2023 · Elsevier eBooks
2. DNA Damage Response and Redox Status in the Resistance of Multiple Myeloma Cells to Genotoxic Treatment
   Panagiotis Malamos, Christina Papanikolaou, Elisavet Deligianni, Dimitra Mavroeidi, Konstantinos Koutoulogenis, Maria Gavriatopoulou, Evangelos Terpos, Vassilis L. Souliotis · 2025 · International Journal of Molecular Sciences
3. Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance
   Elena Alejo, Verónica González‐Calle, Pilar Moix Blázquez, Borja Puertas, Cristina Agulló, Beatriz Rey-Búa, Norma Carmen Gutierrez, Noemí Puig, María‐Victoria Mateos · 2025 · Blood Cancer Journal
4. Diagnosis, risk stratification and management of smouldering multiple myeloma
   Saurabh Zanwar, Shaji Kunnathu Kumar, S. Vincent Rajkumar · 2026 · Nature Reviews Clinical Oncology
5. Subretinal autofluorescent deposits: A review and proposal for clinical classification
   Salomon Yves Cohen, Itay Chowers, Sylvia Nghiem‐Buffet, Sarah Mrejen, Eric H. Souied, Alain Gaudric · 2023 · Survey of Ophthalmology
6. Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe
   Valeria Magarotto, Julien Thevenon, Kate Morgan, Silène Ten Seldam, Wafae Iraqi, Xavier Guillaume, Marjorie Leclerc, Claire Graziani-Taugeron, Bleuenn Rault, Dahbia Horchi · 2024 · Patient Preference and Adherence
7. Senescence profiling of monoclonal gammopathies reveals paracrine senescence as a crucial defense against disease progression
   Gabriel Álvares Borges, Marta Diaz‐delCastillo, Angelo Jose Guilatco, Bilal Mohamad El-Masri, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Nadine H. Abdallah, Linda Banovic Baughn et al. · 2025 · Leukemia
8. Differential Diagnosis of Chronic Spontaneous Urticaria
   Dimitra Gialama, Hanna Bonnekoh, Nikolai Dario Rothermel, Reid Oldenburg, David A. Khan, Hal M. Hoffman, David Lang, Pavel Kolkhir · 2025 · The Journal of Allergy and Clinical Immunology In Practice
9. Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
   Panagiotis Samaras, Mario J. Bargetzi, Daniel C. Betticher, Christoph Driessen, Michel André Duchosal, Dominik A. Heim, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey et al. · 2019 · Swiss Medical Weekly
10. Improving the global reporting of multiple myeloma: a focus on low-income and middle-income countries
    Rajaraman Swaminathan, Nikita Mehra · 2022 · The Lancet Haematology
11. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services
    Mark Trehane Drayson, Tom Jennis, Ira Laketic‐Ljubojevic, Dina Patel, Guy Pratt, SUZANNE B. RENWICK, Alex G Richter, Rachel D. Wheeler, Joanna Sheldon, Ross Sadler et al. · 2024 · British Journal of Haematology
12. A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
    Chaoyuan Kuang, Kevin Quann, Agnes K. Liman, Roy Frye, Nawras Alshoubaki, Mohan Ramkumar, Andrew Dede Liman · 2020 · Clinical Case Reports
13. A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
    Mariarosaria Sessa, Francesco Cavazzini, Maurizio Cavallari, Gian Matteo Rigolin, Antonio Cuneo · 2020 · Genes
14. Reflexing Suspicious β-Region Findings on Capillary Serum Protein Electrophoresis to Immunofixation or Immunosubtraction for Detecting Monoclonal Proteins
    Amanda L Kitson, Alexander S. Taylor, Donald A. Giacherio, David F. Keren · 2021 · American Journal of Clinical Pathology
15. Diagnosis and management of monoclonal gammopathy of clinical significance
    Hyungwoo Cho · 2022 · Blood Research
16. Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study
    Mengmeng Ji, Yi-Hsuan Shih, John H. Huber, Mei Wang, Eric J. Feuer, Ruth Etzioni, Shi‐Yi Wang, Su‐Hsin Chang · 2024 · Cancer Epidemiology Biomarkers & Prevention
17. Whole genome sequencing provides evidence of two biologically and clinically distinct entities of asymptomatic monoclonal gammopathies: progressive versus stable myeloma precursor condition
    Bénedith Oben, Guy Froyen, Kylee H. Maclachlan, Daniel A. Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata D. Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T. Diamond et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
18. Multiple Myeloma Laboratory Diagnostics Made Simple: Practical Insights and Key Recommendations
    Ana Marta Pires, João Pedro Barreto, Joana Caetano, Maria José Soares, Catarina Geraldes, Bruno Fernandes, Margarida Coucelo, Sergio Pereira Chacim, Henrique Guimaraes Barbosa Coelho, Cecília Correia et al. · 2025 · Journal of Clinical Medicine
19. The clinical value of monoclonal protein in ANCA-associated vasculitis with renal involvement
    Yue Wang, Ke Yang, Zhikai Yu, Yinghui Huang, Ting He, Jiachuan Xiong, Jinghong Zhao · 2023 · International Urology and Nephrology
20. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
    Anping Xu, Tong Guo, Shuping Zhang, Hou‐Long Luo, Mengxue Shen, Yinghui Ye, Ling Ji · 2024 · Hematology
21. Multi-omics profiling and AI-driven clinically deployable risk models in MGUS and smoldering myeloma
    Yanyun Wu, Dongliang Zhang, Jingyao Jiang, Linghui Zheng, Zhiming Zhou, Zhenxing Zhang, Sina Nouri · 2025 · Clinical and Experimental Medicine
22. Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins
    J. Ashby, D. Mcentee, Dhananjay S. Sakrikar, L. Ouverson, Rhiannon Stanton, Nia L. Marrott, Roshani R. Patel, Cristina Simion, Syreeta Allen, Manisha Bhutani et al. · 2026 · Clinica Chimica Acta
23. PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
    Mario Sabatelli, Luca Laurenti, Marco Luigetti · 2018 · Mediterranean Journal of Hematology and Infectious Diseases
24. Diagnostic relevance of 2‐[ 18 F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significance
    Teodoro Rudolphi‐Solero, Eva María Triviño‐Ibáñez, Antonio Daniel González Jiménez, Carlos Ramos-Font, Rafael Ríos, Á.C. Rebollo-Aguirre, R. Sánchez Sánchez · 2022 · Hematological Oncology
25. Disease Monitoring In Multiple Myeloma
    Jens Hillengass, Tom G. Martin, Noemí Puig, Bruno Paiva, Saad Z. Usmani, Shaji Kunnathu Kumar, Jesús F. San Miguel · 2023 · Clinical Lymphoma Myeloma & Leukemia
26. Machine Learning-Based Predictive Model for Risk Stratification of Multiple Myeloma from Monoclonal Gammopathy of Undetermined Significance
    Amparo Santamaría, Marcos Alfaro, Cristina Antón Rodríguez, Beatriz Sánchez-Quiñones, Nataly Ibarra, Arturo Gil, Óscar Reinoso, Luis Payá · 2025 · Electronics
27. Langzeit-Follow-up monoklonaler Gammopathien unklarer Signifikanz (MGUS)
    Hartmut Goldschmidt, Sirka Nitschmann · 2018 · Der Internist
28. A Middle-Aged Man Presenting With Progressive Heart Failure, Myopathy, and Monoclonal Gammopathy of Uncertain Significance
    Kaspar Broch, Trine Haug Popperud, Einar Gude, Yngvar Fløisand, Ellen‐Ann Antal, Gerhard Bosse, Christoffer Jonsrud, Terje Hegard, Silje Skaara, Ahmed Elsais · 2020 · JACC Case Reports
29. Laboratory Tests for Neuropathies: What to do and to Avoid
    Corinne G.C. Horlings, Jakob Rath, Josef Finsterer, Julia Wanschitz, Wolfgang N. Löscher · 2020 · Journal of Neuromuscular Diseases
30. Monoclonal gammopathy of undetermined significance (MGUS): where is the hidden danger? Definition and work-up
    Georg Jeryczynski, Maria‐Theresa Krauth · 2020 · memo - Magazine of European Medical Oncology
31. Monoclonal Gammopathy of Undetermined Significance
    2016 · Elsevier eBooks
32. Progress in the Management of Smoldering Multiple Myeloma
    Timothy Martin Schmidt, Natalie S. Callander · 2021 · Current Hematologic Malignancy Reports
33. Diffusion-Weighted MRI—The Way Forward for MRI in Myeloma?
    Jens Hillengaß, Maximilian Merz, Ronald A. Alberico, Majid Chalian · 2021 · Hemato
34. Multi‐trajectory models of serum biomarkers among patients with monoclonal gammopathy of undetermined significance
    Maira A. Castañeda‐Avila, Kate L. Lapane, Sharina D. Person, Yanhua Zhou, Jerry H. Gurwitz, Kathleen M. Mazor, Mara Meyer Epstein · 2022 · Hematological Oncology
35. Prevalence of monoclonal gammopathy of undetermined significance in US black women
    Kimberly A. Bertrand, Gary Zirpoli, Bala Niharika Pillalamarri, Raphael Elie Szalat, Julie R. Palmer, Yachana Kataria · 2022 · American Journal of Hematology
36. Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges
    Romanos Sklavenitis‐Pistofidis, Gad A. Getz, Irene M. Ghobrial, Maria Papaioannou · 2022 · Frontiers in Oncology
37. Bilateral localized primary parotid gland amyloidosis: A rare entity with literature review
    Mohammed Abdelwahed, Alae Kawam, Cecilia Gimenez, Oana C. Rosca · 2023 · Diagnostic Cytopathology
38. Gammapatía monoclonal de significado incierto
    Elena Alejo, Borja Puertas, María‐Victoria Mateos · 2023 · Medicina Clínica
39. Association of monoclonal gammopathy of undetermined significance and C3 glomerulopathy
    Adel Ekladious, Ritesh Bhandari, Muhammad Masoom Javaid · 2023 · Internal Medicine Journal
40. Monoclonal Gammopathy May Be of Unpredictable Significance
    Nikhil C. Munshi, Sundar Jagannath, Hervé Avet‐Loiseau · 2019 · JAMA Oncology
41. Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins
    Sabine Karam, Nelson Leung · 2020 · Hematology/Oncology Clinics of North America
42. A pharmacist’s review of the treatment of systemic light chain amyloidosis
    David Hughes, Andrew Staron, Vaishali Sanchorawala · 2020 · Journal of Oncology Pharmacy Practice
43. Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio
    Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Niels Abildgaard, Henrik Gregersen, Trine Silkjær, Per Trøllund Pedersen, Robert Schou Pedersen, Carsten Helleberg, Emil Hermansen, Brian Iversen Schnack et al. · 2021 · Blood Cancer Journal
44. Oncologist perspective: role of imaging in myeloma
    Yael N. Shapiro, Elizabeth O’Donnell · 2021 · Skeletal Radiology
45. The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity
    Francesco Maura, David Glen Coffey, Caleb K. Stein, Esteban Braggio, Bachisio Ziccheddu, Meaghen E. Sharik, Megan T. Du, Yuliza Tafoya Alvarado, Chang-Xin Shi, Yuan Xiao Zhu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
46. Racial disparities in multiple myeloma
    Erius Tebuka, Peter Rambau, Leo Rasche · 2025 · Blood Global Hematology
47. SECURE study: Incidentally detected MGUS patients have comparable depression and anxiety rates to UK general population
    Elizabeth Knight, Sherin Varghese, Constantinos Koshiaris, Sulgi Byun, Richard Brouwer, Sæmundur Rögnvaldsson, Guy Pratt, Stella J. Bowcock, Ross Sadler, Aimee Maloney et al. · 2025 · British Journal of Haematology
48. An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies
    Xin Xin, Chunhui Fan, Ran Sheng, X C Li, Xing Zhu, Yongsheng Huang, Hamideh Rahmani Seraji, Dilbar Urazbaeva, Zamira Atamuratova, Abdullaeva Dilbar Ubaydullaevna · 2026 · Clinical and Experimental Medicine
49. M-protein interference in laboratory diagnostics: a comprehensive narrative review of mechanisms and management strategies
    Shanshan Liang, Xinyu Wang, Lin Peng, Xiaoling Li, Chengyao Jia, Chuanmin Tao, Wei Gan · 2026 · Clinical Chemistry and Laboratory Medicine (CCLM)
50. Gaucher disease: the hematologist’s perspective of a multisystemic disorder
    Alessandro Costa, Olga Mulas, Giovanni Caocci · 2026 · Annals of Hematology
51. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima
    Kingo Fujimura, Aya Sugiyama, Tomoyuki Akita, Masayuki Ohisa, Shintaro Nagashima, Keiko Katayama, Ryo Maeda, Junko Tanaka · 2021 · International Journal of Hematology
52. Gammapatía monoclonal de significado incierto y evolución a mieloma múltiple: Experiencia en 153 pacientes
    Juan Manuel López Gómez, Beatriz Sacristán Enciso, María Jesús Fernández-Cavada Pollo, Virginia Bueno García, Sergio Gómez Vera · 2021 · Medicina de Familia SEMERGEN
53. Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes
    Marie-Sophie Meuleman, Steven Mouyabi, Juliette Gueguen, Stéphanie Vicca, Gillian Divard, Olivier Aubert, Frank Bienaimé, Bertrand Arnulf, Dany Anglicheau, Frank Bridoux et al. · 2023 · Nephrology Dialysis Transplantation
54. Screening for and diagnosis of monoclonal gammopathy
    Yuh‐Ping Chong, Say Min Lim, Tze Ping Loh, Peter N. Mollee, Nilika G. Wijeratne, Kay Weng Choy · 2023 · Journal of Clinical Pathology
55. Haemato-radiology: the role of the radiologist at MDT
    Omnya Ahmed, Katherine Ordidge, Tahir Hussain, Adeel Syed, Athar Haroon, Khawaja Shahabuddin · 2024 · British Journal of Radiology
56. Top 10 Clinical Pearls in Paraproteinemic Neuropathies
    Benjamin Becker, Amro Maher Stino · 2024 · Seminars in Neurology
57. Amyloidosis and the Liver
    Rama Tarakji, Paul B. Martin, Gabriel Perreault · 2025 · Clinics in Liver Disease
58. Association Between Monoclonal Gammopathy of Undetermined Significance and Cardiovascular Disease Risk: A Veterans Health Administration Study
    Tzeyu L. Michaud, Mei Wang, Daphne Ruth Friedman, Lawrence Liu, Theodore Seth Thomas, Kristen Marie Sanfilippo, Graham A. Colditz, Martin William Schoen, Su‐Hsin Chang · 2025 · Journal of the American Heart Association
59. Maladie de Waldenström
    Cécile Tomowiak, Stéphanie Poulain, Celine Debiais, Stéphanie Guidez, Xavier P Leleu · 2019 · La Presse Médicale
60. MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease
    Xu Zhao, Yifeng Sun, Tianhong Xu, Yidan Shi, Lifan Liang, Peng Liu, Junbo Ge · 2020 · Journal of Cardiovascular Translational Research
61. Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?
    Carmelo Gurnari, Simona Pagliuca, Hassan K. Awada, Misam Zawit, Bhumika J. Patel, Valeria Visconte, Jason Neil Valent, Heesun Joyce Rogers, Jaroslaw Pawel Maciejewski · 2021 · Blood Cells Molecules and Diseases
62. Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy
    Juhee Lee, Han Sang Lee, Kon Chu · 2021 · encephalitis
63. Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
    Dana M. Lewis, Nancy T.H. Colchester, David C. Allen, James A. R. Nicoll, Haider A. Katifi, Andrew S. Duncombe · 2022 · Case Reports in Neurology
64. Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients
    Loredana Mihaiela Dragos, Iuliu Cristian Ivanov, Mihaela Mențel, Irina-Cezara Văcărean-Trandafir, Adriana Sireteanu, Amalia A. Titianu, Angela Smaranda DASCALESCU, Alexandru Bogdan Stache, Daniela Jitaru, Lucian Gorgan · 2022 · International Journal of Molecular Sciences
65. Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
    Cecilia Napodano, Laura Ioannilli, Valerio Basile, Francesca Gulli, Valeria Carnazzo, Stefano Pignalosa, Luigi Di Biase, Erica Cavaleri, Cosimo Racco, Francesco Equitani et al. · 2023 · Journal of Personalized Medicine
66. Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View
    Сергей Вячеславович Семочкин · 2024 · Clinical oncohematology
67. A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain
    Hanna Bonnekoh, Melba Muñoz, Pavel Kolkhir · 2025 · JAMA
68. Monoklonale Gammopathie unklarer Signifikanz – ein häufiger Nebenbefund
    Aneta Schieferdecker, Mascha Binder, Katja Christina Weisel, Carsten Bokemeyer · 2019 · DMW - Deutsche Medizinische Wochenschrift
69. Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis
    Hamza Hassan, Faiz Anwer, Anum Javaid, Hamza Hashmi · 2021 · Critical Reviews in Oncology/Hematology
70. CIDP and hemopathies, an underestimated association
    Nathalie Deschamps, Stéphane Mathis, Mathilde Duchesne, Karima Ghorab, G Gallouëdec, Laurence Richard, Jean-Marc Boulesteix, Philippe Corcia, Laurent Magy, Jean‐Michel Vallat · 2021 · Journal of the Neurological Sciences
71. Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study
    Nicola Sgherza, Paola Curci, Rita Rizzi, Vanda Strafella, Daniela Di Gennaro, Angelantonio Vitucci, António M. Palma, Antonella Russo Rossi, Francesco Albano, Pasquale Stefanizzi et al. · 2021 · Haematologica
72. The MYD88L265P conundrum in IgM monoclonal gammopathy of undetermined significance
    Prashant Kapoor · 2019 · British Journal of Haematology
73. Machine Learning Models for Predicting Multiple Myeloma Staging and MGUS Progression Using Gene Expression Data
    Nestoras Karathanasis, George M. Spyrou · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
74. Monoclonal gammopathy in autoimmune diseases: Analysis and follow-up of 160 cases in a tertiary center in China
    Huazhen Liu, Pengchong Li, Ketian Li, Ziyue Zhou, Yangzhong Zhou, Xiaomei Leng, Lidan Zhao, Xuan Zhang · 2021 · Clinical Immunology
75. Insuffisance rénale dans le myélome multiple : particularités de la prise en charge
    Mélanie Try, Stéphanie Harel · 2023 · Bulletin du Cancer
76. Metabolic profile analysis in hematological malignancies
    Piotr Halicki, Klaudia Cieśluk, Jaroslaw A. Piszcz · 2024 · Acta Haematologica Polonica
77. Kidney thrombotic microangiopathy with concurrent monoclonal gammopathy
    Meng Tan, Changhao Jia, Xiaotian Liu, Daoxu Wu, Xiaojuan Yu, Minghui Zhao, Ying Tan · 2024 · Nephrology Dialysis Transplantation
78. Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging Association
    Fabrizio Martora, Teresa Battista, Antonella Giordano, Luca Potestio, Matteo Megna · 2025 · Clinical Cosmetic and Investigational Dermatology
79. Engineered Biomimetic Nanomedicine for Enhanced Bone Marrow Targeted Delivery and Therapy in Multiple Myeloma
    Mengyuan Xu, Xiaoqian Zhang, Xindi Zou, Jia‐Wei Feng, Haitao Liang, Tingting Chen, Tao Zhong, Limin Li · 2025 · ACS Applied Nano Materials
80. Case Report: IgG4-RD-related ophthalmopathy combined with monoclonal gammopathy of undetermined significance
    Shanshan Liang, Wei Xu, Peiying Zhong, Chuanmin Tao, Li Zhang, Chengyao Jia · 2025 · Frontiers in Immunology
81. Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure
    Jeries Kort, Andrew Rivera, Sindhuja Senigarapu, James Joseph Driscoll · 2025 · Frontiers in Oncology
82. Recent developments in systemic light-chain amyloidosis prognosis and treatment
    Adam Ioannou · 2025 · Future Cardiology
83. Precursor plasma cell disorders: Classification, risk stratification, and emerging role of early interception
    Tarek H. Mouhieddine, Irene M. Ghobrial, Omar Nadeem · 2025 · Best Practice & Research Clinical Haematology
84. Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
    Rajvi Gor, Jeevan Shivakumar, Pallavi Surana, John X Wei, Irina Murakhovskaya, Mendel Goldfinger, Noah Saul Kornblum, Lauren C. Shapiro, Aditi Shastri, Ridhi Gupta et al. · 2025 · Blood Cancer Journal
85. Lymphoma driver mutations at the root of somatic evolution of nerve-damaging autoantibodies in myelin associated glycoprotein neuropathy
    Shane Kelly, Mandeep Singh, Amanda J. Russell, Katherine Jackson, Timothy J. Peters, Andrew D Carr, Anthony Dominic Kelleher, Matthew A. Field, Matthew Silsby, Dan Suan et al. · 2025 · Journal of Autoimmunity
86. Clinical Utility of Monoclonal Gammopathy Testing in the Evaluation of Anemia
    Mackenzie D. Maberry, Caleb Joshua Smith, Ronald S. Go · 2025 · American Journal of Hematology
87. Linvoseltamab, a BCMA-directed CD3 T-cell engager for multiple myeloma: a patient-centric option via a response-adapted dosing regimen
    Jacob Alexander Lowy, Michael F. Rogers, Zachary M. Avigan, Marcus S. Flores, Marina Samuel, Mohammad A. Rattu, Joshua Richter · 2026 · Expert Review of Hematology
88. A Single-Center Retrospective Study to Investigate the Follow-Up of Patients with Monoclonal Proteinemia by Community Physicians in the UK
    Indra Ramasamy · 2020 · Journal of Blood Medicine
89. Immune subtraction for improved resolution in serum protein immunofixation electrophoresis and antibody isotype determination in a patient with autoantibody
    Asad Ullah, Nivin Omar, Natasha M. Savage, Roni J. Bollag, Gurmukh Singh · 2021 · Practical Laboratory Medicine
90. Light chain cardiac amyloidosis in a nonagenarian.
    Koji Takahashi, Mina Yamashita, Tomoki Sakaue, Daijiro Enomoto, Shigeki Uemura, Takafumi Okura, Shuntaro Ikeda, Takanori Senba, Akira Saijo, Nobuhisa Yamamura et al. · 2022 · PubMed Central
91. Intramedullary nailing for pathological fractures of the proximal humerus caused by multiple myeloma: A case report and review of literature
    Guoqiang Xu, Gang Wang, Xiaodong Bai, Zhenyu Liu, Xinjia Wang, baojun wang · 2022 · World Journal of Clinical Cases
92. Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance
    Maira A. Castañeda‐Avila, Kate L. Lapane, Sharina D. Person, Bill M. Jesdale, Yanhua Zhou, Kathleen M. Mazor, Mara Meyer Epstein · 2022 · Cancer Control
93. Waldenström’s macroglobulinemia – clinical symptoms and review of therapy yesterday, today and tomorrow
    Zdeněk Adam, Luděk Pour, David Zeman, Marta Krejčí, Ivanna Boichuk, Martin Krejčí, Martin Štork, Viera Sandecká, Zdeněk Král · 2023 · Klinicka onkologie
94. A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up
    Larry Don Anderson, Joan Bladé, Robert A. Kyle · 2024 · eJHaem
95. Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib
    Kai Deng, Qiongqiong Li, Lina Lu, Luting Wang, Zhiyong Cheng, S Z Wang · 2024 · Biochemistry and Biophysics Reports
96. Unleashing the Impact of Exosomes Derived from Human Placental Mesenchymal Stem Cells (hPMSCs) on U-266 Myeloma Cell Line
    Ayda Baghery Saghchy Khorasani, Mina Soufi Zomorrod, Davood Bashash · 2024 · International Journal of Hematology-Oncology and Stem Cell Research
97. Therapeutic potentials of adoptive cell therapy in immune-mediated neuropathy
    Siqi Shang, Chongbo Zhao, Jie Lin · 2024 · Journal of Autoimmunity
98. Focal and Segmental Glomerulosclerosis in a Multiple Myeloma Patient After Belantamab Mafodotin Therapy and Severe COVID-19 Infection: A Case Report
    Mohamed Sabbah, Stéphanie Nguyen, Maya Ouzegdouh, Sylvain Choquet, David Buob, J.J. Boffa, Alexandre Cez, Laurent Garderet · 2024 · American Journal of Case Reports
99. Patient preferences for intervention in the setting of precursor multiple myeloma
    Catherine R. Marinac, Katelyn Downey, Jacqueline F Perry, Brittany Fisher-Longden, Timothy Richard Rebbeck, Urvi Ashok Shah, Elizabeth O’Donnell, Irene M. Ghobrial, Omar Nadeem, Brian Lee Egleston · 2024 · Blood Cancer Journal
100. Quantitative abnormalities in the β-region of the electrophoretic profile of serum proteins as predictive markers of monoclonality: Machine learning for monoclonality prediction
     Sara Cherkaoui, Slavka Penickova, FREDERIC JAY COTTON · 2025 · Clinical Biochemistry